Home / Market News / $ALPN

$ALPN news and market catalysts

The 1 most recent market catalysts affecting $ALPN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

1 catalysts 0 high impact 0 bullish 0 bearish Biotechnology
Nov 12, 2026 Corporate Catalyst Neutral Impact 75
Alpha Tau Medical to Host Conference Call to Discuss REGAIN Trial Interim Results
Alpha Tau Medical is hosting a conference call to discuss interim results from its U.S. multicenter REGAIN trial, which evaluates its Alpha DaRT therapy for recurrent glioblastoma.…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.